Monitoring of cancer patients undergoing active or passive immunotherapy

被引:19
作者
Salgaller, ML
机构
[1] Immunotherapeuties Division, Northwest Biotherapeutics L.L.C, Seattle, WA, 98125-7001, 120 Northgate Plaza
来源
JOURNAL OF IMMUNOTHERAPY | 1997年 / 20卷 / 01期
关键词
D O I
10.1097/00002371-199701000-00001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 14
页数:14
相关论文
共 117 条
[1]  
Abbas A.K., 1994, Cellular and molecular immunology
[2]   CLONAL ANALYSIS OF THE CYTOLYTIC T-CELL RESPONSE TO HUMAN-TUMORS [J].
ANICHINI, A ;
FOSSATI, G ;
PARMIANI, G .
IMMUNOLOGY TODAY, 1987, 8 (12) :385-389
[3]   MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100 IS RECOGNIZED BY MELANOMA-DERIVED TUMOR-INFILTRATING LYMPHOCYTES [J].
BAKKER, ABH ;
SCHREURS, MWJ ;
DEBOER, AJ ;
KAWAKAMI, Y ;
ROSENBERG, SA ;
ADEMA, GJ ;
FIGDOR, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :1005-1009
[4]  
BARTH A, 1994, CANCER RES, V54, P3342
[5]  
Bear HD, 1996, SEMIN SURG ONCOL, V12, P436
[6]  
BERD D, 1993, ANN NY ACAD SCI, V690, P147
[7]   TREATMENT OF METASTATIC MELANOMA WITH AN AUTOLOGOUS TUMOR-CELL VACCINE - CLINICAL AND IMMUNOLOGICAL RESULTS IN 64 PATIENTS [J].
BERD, D ;
MAGUIRE, HC ;
MCCUE, P ;
MASTRANGELO, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (11) :1858-1867
[8]   Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors [J].
Blachere, NE ;
Srivastava, PK .
SEMINARS IN CANCER BIOLOGY, 1995, 6 (06) :349-355
[9]  
BLAY JY, 1990, CANCER RES, V50, P2371
[10]  
BLAY JY, 1992, CANCER RES, V52, P3317